Abstract
Lidocaine (lignocaine) was given in 42 episodes of status epilepticus (SE) in 36 patients either because of limited pulmonary reserve (22 patients) or because of lack of response to diazepam (14 patients). Lidocaine (1.5-2 mg/kg) was given intravenously in two minutes. A further identical bolus was infused if no response had occurred or if seizures recurred. With the first bolus 11 episodes of SE did not stop, but 31 responded, always in less than one minute. In 19 episodes, however, this response lasted less than 30 minutes. Twelve episodes did not recur, but 30 needed a second bolus because of recurrence. Of these, 19 episodes responded at once but SE reappeared in seven. In these seven episodes the mean control time with the second dose was 102 minutes. Five of these subsequently responded to a continuous infusion of lidocaine. Eleven patients, who had not responded to the first bolus, had no response to the second. Lidocaine is a drug that may be epileptogenic at high doses. At the doses used here, however, lidocaine seems to be a rapid acting anticonvulsant, useful in the short term management of SE and may be indicated in patients in whom respiratory or consciousness depression is undesirable and in those with no response to diazepam. The absence of response to lidocaine indicates SE resistant to treatment and poor prognosis. These data show that prompt lidocaine administration may be worthwhile when management of respiratory depression is not possible.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Delgado-Escueta A. V., Wasterlain C., Treiman D. M., Porter R. J. Current concepts in neurology: management of status epilepticus. N Engl J Med. 1982 Jun 3;306(22):1337–1340. doi: 10.1056/NEJM198206033062205. [DOI] [PubMed] [Google Scholar]
- GODBER G. E. Health services, past, present and future. Lancet. 1958 Jul 5;2(7036):1–6. doi: 10.1016/s0140-6736(58)90001-1. [DOI] [PubMed] [Google Scholar]
- Hellström-Westas L., Westgren U., Rosén I., Svenningsen N. W. Lidocaine for treatment of severe seizures in newborn infants. I. Clinical effects and cerebral electrical activity monitoring. Acta Paediatr Scand. 1988 Jan;77(1):79–84. doi: 10.1111/j.1651-2227.1988.tb10602.x. [DOI] [PubMed] [Google Scholar]
- Lemmen L. J., Klassen M., Duiser B. Intravenous lidocaine in the treatment of convulsions. JAMA. 1978 May 12;239(19):2025–2025. doi: 10.1001/jama.239.19.2025. [DOI] [PubMed] [Google Scholar]
- Leppik I. E., Derivan A. T., Homan R. W., Walker J., Ramsay R. E., Patrick B. Double-blind study of lorazepam and diazepam in status epilepticus. JAMA. 1983 Mar 18;249(11):1452–1454. [PubMed] [Google Scholar]
- Nattel S., Gagne G., Pineau M. The pharmacokinetics of lignocaine and beta-adrenoceptor antagonists in patients with acute myocardial infarction. Clin Pharmacokinet. 1987 Nov;13(5):293–316. doi: 10.2165/00003088-198713050-00002. [DOI] [PubMed] [Google Scholar]
- Pascual J., Sedano M. J., Polo J. M., Berciano J. Intravenous lidocaine for status epilepticus. Epilepsia. 1988 Sep-Oct;29(5):584–589. doi: 10.1111/j.1528-1157.1988.tb03766.x. [DOI] [PubMed] [Google Scholar]
- Tsukamoto S., Horiike N., Hisanaga M., Utsumi S. [The efficacy of lidocaine in the status epilepticus (author's transl)]. No To Shinkei. 1980 Apr;32(4):363–368. [PubMed] [Google Scholar]
- Westreich G., Kneller A. W. Intravenous lidocaine for status epilepticus. Minn Med. 1972 Sep;55(9):807–808. [PubMed] [Google Scholar]